// App-Quantinova.ai

TCT-705 : The Prognostic Value of Residual Coronary Stenosis After “Functionally” Complete Revascularization in Acute Coronary Syndrome: Insights from the DANAMI-3-PRIMULTI, FAME, and FAMOUS-NSTEMI

Researchers

Presenter

  • Yuhei Kobayashi

Principal Investigators

  • Jacob Lonborg

  • Andy Jong

  • Takeshi Nishi

  • Bernard De Bruyne

  • Dan Eik Høfsten

  • Henning Kelbæk

  • Jamie Layland

  • Chang-Wook Nam

  • Nico Pijls

  • Pim Tonino

  • Julie Warnøe

  • Keith Oldroyd

  • Colin Berry

  • Thomas Engstroem

  • William Fearon

Medical Centers

  • Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, United States

  • Peninsula Health, Frankston, Victoria, Australia

  • The Heart Centre, University of Copenhagen, Copenhagen, Denmark

  • Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of

  • Golden Jubilee National Hospital, Glasgow, Scotland, United Kingdom

  • Stanford University, Stanford, California, United States

  • Catharina hospital, Eindhoven, Netherlands

  • catharina Hospital Eindhoven Netherlands, Eindhoven, Netherlands

  • Cardiovascular Centre Aalst, AALST, Belgium

  • Rigshospitalet, Copenhagen, Denmark

  • Roskilde Hospital, Roskilde, Denmark

  • University of Glasgow, Glasgow, United Kingdom

  • Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Locations

  • United States

  • Belgium

  • Denmark

  • Netherlands

  • United Kingdom

  • Australia

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final